Braasch Biotech

Braasch Biotech is a private, established player in the biologics and vaccines space, leveraging over two decades of experience in development and manufacturing. While specific pipeline details are not publicly disclosed, its focus spans both therapeutics and diagnostics, suggesting a diversified approach within the biopharma sector. The company's longevity since 2003 indicates it has navigated the capital-intensive biotech landscape, likely operating as a revenue-generating entity through development services, manufacturing, or partnered programs, though its precise business model and financials remain private.

Capabilities in biologics and vaccine development and manufacturing, including potential cell culture, purification, and formulation processes. Also involved in diagnostic assay development.

Braasch Biotech competes in the crowded biologics CDMO space against giants like Lonza, Catalent, and Samsung Biologics, as well as numerous niche players. In vaccine and therapeutic development, it competes with thousands of biotech firms. Its competitive edge likely hinges on specialized technical expertise, customer service, and flexibility as a private, mid-sized entity.